Antiplatelet Agents for Preventing Vaso-occlusive Events in People With Sickle Cell Disease: A Systematic Review

  Abstract: Background: Sickle cell disease (SCD) is the most common hemoglobinopathy, occurring worldwide, and vaso-occlusive events (VOEs) are its paramount, hallmark clinical manifestation. Evidence exists […]